Intellipharmaceutics International Inc. IPCIF

Full chart Compare
Set alert

Price alert · IPCIF

All alert types
0.15 +0.15

Day range unavailable

52-week range unavailable

Revenue & Expenses

Revenue → Gross Profit: $65.73KGross Profit → Expenses: $65.73KExpenses → Selling, General & Admin: $561.05KExpenses → Research & Development: $2.15MExpenses → Other Operating Expenses: $206.06KExpenses → Other Expenses: $36.55KExpenses → Income Tax: $5.34KNet Loss → Expenses: $2.89MGross Profit$65.73KNet Loss$2.89MExpenses$2.96MSelling, General & Admin$561.05KResearch & Development$2.15MOther Operating Expenses$206.06KOther Expenses$36.55KIncome Tax$5.34KRevenue$65.73K

Latest period ending Nov 30, 2022 · select a line to chart its full history

Annual income statement

IPCIF annual income statement
Fiscal yearFY 2022 Nov 30, 2022FY 2021 Nov 30, 2021FY 2020 Nov 30, 2020FY 2019 Nov 30, 2019FY 2018 Nov 30, 2018
65.73K01.40M3.48M1.71M
65.73K01.40M3.48M1.71M
65.73K01.40M3.45M1.59M
2.92M4.17M3.58M11.28M14.91M
2.15M2.66M3.52M6.61M10.83M
561.05K1.25M2.15M4.17M3.48M
-2.85M-4.17M-2.18M-7.83M-13.33M
291.62K549.30K969.65K247.52K255.23K
5.34K-114.19K32.83K-5.36K0
-2.89M-5.15M-3.39M-8.08M-13.75M
-2.89M-5.15M-3.39M-8.08M-13.75M
-2.89M-5.15M-3.39M-8.08M-13.75M
-2.89M-5.15M-3.39M-8.08M-13.75M
-0.09-0.17-0.14-0.37-2.89
-0.09-0.17-0.14-0.37-2.89
-0.09-0.17-0.14-0.37-2.89
-2.60M-4.71M-2.39M-7.84M-13.49M
-2.60M-4.71M-2.39M-7.84M-13.49M
33.09M29.43M23.56M21.58M4.76M
33.09M29.43M23.56M21.58M4.76M